[Congressional Record Volume 163, Number 7 (Wednesday, January 11, 2017)]
[Senate]
[Page S294]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 187. Mr. WYDEN (for himself and Mr. Sanders) submitted an 
amendment intended to be proposed by him to the concurrent resolution 
S. Con. Res. 3, setting forth the congressional budget for the United 
States Government for fiscal year 2017 and setting forth the 
appropriate budgetary levels for fiscal years 2018 through 2026; which 
was ordered to lie on the table; as follows:

       At the end of title IV, add the following:

     SEC. 4__. POINT OF ORDER AGAINST LEGISLATION THAT DOES NOT 
                   LOWER DRUG PRICES.

       (a) Findings.--The Senate finds the following:
       (1) Total annual drug spending in the United States is 
     projected to reach more than $500,000,000,000 by 2018.
       (2) One out of five Americans age 19 to 64 cannot afford to 
     fill their prescriptions.
       (3) Spending on prescription drugs in the United States 
     grew by 12 percent in 2014, faster than in any year since 
     2002.
       (4) Medicare part D drug spending was $90,000,000,000 in 
     2015, and is expected to increase to $216,000,000,000 by 
     2025.
       (5) Medicare part B drug spending also more than doubled 
     between 2005 and 2015, increasing from $9,000,000,000 in 2005 
     to $22,000,000,000 in 2015.
       (6) In 2014, prescription drug spending in Medicaid 
     increased by 24 percent.
       (7) During the Presidential campaign, the President-elect 
     said, ``When it comes time to negotiate the cost of drugs, 
     we're going to negotiate like crazy, folks'' and his campaign 
     website said that, ``allowing consumers access to imported, 
     safe and dependable drugs from overseas will bring more 
     options to consumers.''.
       (8) After being elected, the President-elect said, ``I'm 
     going to bring down drug prices. I don't like what's happened 
     with drug prices.''.
       (9) On January 11, 2017, the President-elect said, ``We 
     have to create new bidding procedures for the drug industry, 
     because they are getting away with murder.''.
       (b) Point of Order.--It shall not be in order in the Senate 
     to consider a bill or joint resolution reported pursuant to 
     section 2001 or 2002, or an amendment to, motion on, 
     conference report on, or amendment between the Houses in 
     relation to such a bill or joint resolution that does not, as 
     promised by the President-elect, lower drug prices as 
     certified by the Congressional Budget Office.
       (c) Waiver and Appeal.--Subsection (b) may be waived or 
     suspended in the Senate only by an affirmative vote of three-
     fifths of the Members, duly chosen and sworn. An affirmative 
     vote of three-fifths of the Members of the Senate, duly 
     chosen and sworn, shall be required to sustain an appeal of 
     the ruling of the Chair on a point of order raised under 
     subsection (b).
                                 ______